Quarterly report [Sections 13 or 15(d)]

Earnings Per Share (Tables)

v3.25.1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:
(in thousands, except per share data) Three Months Ended March 31,
  2025 2024
Numerator
Net increase (decrease) in net assets resulting from operations $ 50,337  $ 90,964 
Less: Total distributions declared (81,384) (76,031)
Total Earnings (loss), net of total distributions (31,047) 14,933 
Earnings (loss), net of distributions attributable to common shares (31,048) 14,776 
Add: Distributions declared attributable to common shares 80,616  75,230 
Numerator for basic change in net assets per common share 49,568  90,006 
Add: Income impact of assumed conversion of 2028 Convertible Notes 904 —
Numerator for diluted change in net assets per common share $ 50,472  $ 90,006 
Denominator
Basic weighted average common shares outstanding 171,494 157,445
Incremental shares from assumed conversion of 2028 Convertible Notes 3,272 —
Common shares issuable 617 475
Weighted average common shares outstanding assuming dilution 175,383 157,920
Change in net assets per common share:
Basic $ 0.29  $ 0.57 
Diluted $ 0.29  $ 0.57 
Schedule of Number of Anti-diluted Shares as Calculated Based on Weighted Average Closing Price of Common Stock
The calculation of change in net assets resulting from operations per common share assuming dilution, excludes all anti-dilutive shares. For the three months ended March 31, 2025 and 2024, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:
Three Months Ended March 31,
Anti-dilutive Securities 2025 2024
Unvested common stock options 1,974 2,004
Unvested restricted stock awards 23 895